Holger Weis - 18 Aug 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Chief Executive Officer, Director
Signature
/s/ Holger Weis
Issuer symbol
TCRT
Transactions as of
18 Aug 2025
Net transactions value
$0
Form type
4
Filing time
20 Aug 2025, 19:53:57 UTC
Previous filing
07 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weis Holger Chief Executive Officer, Director C/O ALAUNOS THERAPEUTICS, INC., 501 E. LAS OLAS BLVD., SUITE 300, FORT LAUDERDALE /s/ Holger Weis 20 Aug 2025 0001846984

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +13,676 $0.000000 13,676 18 Aug 2025 Common Stock 13,676 $2.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are fully vested as of August 18, 2025.